» Articles » PMID: 35323375

Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile

Abstract

Previous studies associated high-level exposure to ultraviolet radiation with a greater risk of cutaneous malignant melanoma (CMM). This study focuses on the changing incidence of CMM over time (from 1990 to 2017) in the Veneto region of Northeast Italy, and its Alpine area (the province of Belluno). The clinicopathological profile of CMM by residence is also considered. A joinpoint regression analysis was performed to identify significant changes in the yearly incidence of CMM by sex and age. For each trend, the average annual percent change (AAPC) was also calculated. In the 2017 CMM cohort, the study includes a descriptive analysis of the disease's categorical clinicopathological variables. In the population investigated, the incidence of CMM has increased significantly over the last 30 years. The AAPC in the incidence of CMM was significantly higher among Alpine residents aged 0-49 than for the rest of the region's population (males: 6.9 versus 2.4; females 7.7 versus 2.7, respectively). Among the Alpine residents, the AAPC was 3.35 times greater for females aged 0-49 than for people aged 50+. The clinicopathological profile of CMM was significantly associated with the place of residence. Over three decades, the Veneto population has observed a significant increase in the incidence of CMM, and its AAPC. Both trends have been markedly more pronounced among Alpine residents, particularly younger females. While epidemiology and clinicopathological profiles support the role of UV radiation in CMM, the young age of this CMM-affected female population points to other possible host-related etiological factors. These findings also confirm the importance of primary and secondary prevention strategies.

Citing Articles

Cutaneous melanoma in older patients.

Buja A, Rugge M, Trevisiol C, Zanovello A, Brazzale A, Zorzi M BMC Geriatr. 2024; 24(1):232.

PMID: 38448833 PMC: 10916215. DOI: 10.1186/s12877-024-04806-8.


Flavonoids as Promising Natural Compounds in the Prevention and Treatment of Selected Skin Diseases.

cizmarova B, Hubkova B, Tomeckova V, Birkova A Int J Mol Sci. 2023; 24(7).

PMID: 37047297 PMC: 10094312. DOI: 10.3390/ijms24076324.


Machine learning to predict overall short-term mortality in cutaneous melanoma.

Cozzolino C, Buja A, Rugge M, Miatton A, Zorzi M, Vecchiato A Discov Oncol. 2023; 14(1):13.

PMID: 36719475 PMC: 9889591. DOI: 10.1007/s12672-023-00622-5.


Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study.

Del Fiore P, Russo I, Monico A, Tartaglia J, Ferrazzi B, Mazza M Life (Basel). 2022; 12(5).

PMID: 35629411 PMC: 9146073. DOI: 10.3390/life12050745.

References
1.
Rugge M . Gastric cancer risk: between genetics and lifestyle. Lancet Oncol. 2020; 21(10):1258-1260. DOI: 10.1016/S1470-2045(20)30432-0. View

2.
DEcclesiis O, Caini S, Martinoli C, Raimondi S, Gaiaschi C, Tosti G . Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors: A Systematic Review. Int J Environ Res Public Health. 2021; 18(15). PMC: 8345480. DOI: 10.3390/ijerph18157945. View

3.
Zink A, Thome F, Schielein M, Spinner C, Biedermann T, Tizek L . Primary and secondary prevention of skin cancer in mountain guides: attitude and motivation for or against participation. J Eur Acad Dermatol Venereol. 2018; 32(12):2153-2161. DOI: 10.1111/jdv.15095. View

4.
Buja A, Sartor G, Scioni M, Vecchiato A, Bolzan M, Rebba V . Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines. Acta Derm Venereol. 2017; 98(2):218-224. DOI: 10.2340/00015555-2830. View

5.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View